Grassley Seeks FDA Briefing on Steps to Ensure Safety of Foreign-made Medicine
WASHINGTON – Sen. Chuck Grassley, ranking member of the Committee on Finance, is asking the Food and Drug Administration for an explanation of its steps to ensure the safety of foreign-made medicine. In a letter to the agency commissioner, Grassley said he is disturbed by reports of the inadequacy of FDA inspections of foreign pharmaceutical manufacturing facilities, especially given the growing predominance of overseas manufacturing of such products.
The text of Grassley’s letter follows here.
Next Article Previous Article
- Wyden Statement on House Republican International Tax Bill
- Wyden Offers Support for Biden Stance on Work Reporting Requirements
- Wyden Requests Information on How Medicare Will Administer Coverage for New Alzheimer's Medications
- Wyden, Beyer Call on DOJ to Crack Down on Swiss Banks Enabling Tax Evasion, Prosecute Bankers Involved
- Wyden Continues Investigation Into Foreign Banks Enabling U.S. Tax Evasion